Featured
-
-
Research Letter |
Spironolactone increases serum uric acid levels in patients with chronic kidney disease
- S E Cabrera
- , N C Edwards
- & C J Ferro
-
-
Original Article |
Efficacy and safety of aliskiren and amlodipine combination therapy in patients with hypertension: a randomized, double-blind, multifactorial study
- T W Littlejohn III
- , S W Jones
- & D L Keefe
-
Original Article |
Distinct effects of fixed combinations of valsartan with either amlodipine or hydrochlorothiazide on lipoprotein subfraction profile in patients with hypertension
- L G Christogiannis
- , M S Kostapanos
- & M S Elisaf
-
Original Article |
Effects of valsartan and amlodipine on home blood pressure and cardiovascular events in Japanese hypertensive patients: a subanalysis of the VART
- H Takano
- , H Hasegawa
- & I Komuro
-
Original Article |
Low-dose atorvastatin reduces ambulatory blood pressure in patients with mild hypertension and hypercholesterolaemia: a double-blind, randomized, placebo-controlled study
- A I Kanaki
- , P A Sarafidis
- & A N Lasaridis
-
Letter to the Editor |
The ‘pyrrhic victory’ of amlodipine over hydrochlorothiazide in the OLAS study: response from the authors
- F J Martinez-Martin
-
-
Letter to the Editor |
The ‘pyrrhic victory’ of amlodipine over hydrochlorothiazide in the OLAS Study
- C Thomopoulos
- , C Tsioufis
- & C Stefanadis
-
Original Article |
Effects of high dose olmesartan medoxomil plus hydrochlorothiazide on blood pressure control in patients with grade 2 and grade 3 hypertension
- L C Rump
- , X Girerd
- & J Stegbauer
-
Original Article
| Open AccessOlmesartan/amlodipine vs olmesartan/hydrochlorothiazide in hypertensive patients with metabolic syndrome: the OLAS study
- F J Martinez-Martin
- , H Rodriguez-Rosas
- & C Comi-Diaz
-
Original Article |
Effects of fluvastatin on insulin resistance and cardiac morphology in hypertensive patients
- A A Teixeira
- , A Buffani
- & M C Batista
-
Original Article |
Efficacy and safety of olmesartan medoxomil plus amlodipine in age, gender and hypertension severity defined subgroups of hypertensive patients
- R E Schmieder
- & M Böhm
-
Original Article |
Effects of protein coding polymorphisms in the kallikrein 1 gene on baseline blood pressure and antihypertensive response to irbesartan in Chinese hypertensive patients
- S Jiang
- , Y-H Hsu
- & X Xu
-
Original Article |
Safety and efficacy of oral anticoagulation therapy in Chinese patients with concomitant atrial fibrillation and hypertension
- L Y Ho
- , C W Siu
- & H F Tse
-
Original Article |
Antihypertensive and renoprotective effects of trandolapril/verapamil combination: a meta-analysis of randomized controlled trials
- Z Zou
- , F-Y Xu
- & X-Y Shi
-
Original Article |
Contribution of nitric oxide to the blood pressure and arterial responses to exercise in humans
- R Campbell
- , J P Fisher
- & M P Frenneaux
-
Original Article |
Effects of nebivolol in obese African Americans with hypertension (NOAAH): markers of inflammation and obesity in response to exercise-induced stress
- N Merchant
- , S T Rahman
- & B V Khan
-
Original Article |
Comparative efficacy and safety of aliskiren and irbesartan in patients with hypertension and metabolic syndrome
- W Krone
- , M Hanefeld
- & W P Dole
-
Original Article |
Blood pressure control has distinct effects on executive function, attention, memory and markers of cerebrovascular damage
- A Semplicini
- , G Inverso
- & R Manara
-
Original Article
| Open AccessLong-term efficacy of a combination of amlodipine and olmesartan medoxomil±hydrochlorothiazide in patients with hypertension stratified by age, race and diabetes status: a substudy of the COACH trial
- S Oparil
- , S G Chrysant
- & R Heyrman
-
Original Article |
Efficacy, safety and tolerability of aliskiren, a direct renin inhibitor, in women with hypertension: a pooled analysis of eight studies
- A H Gradman
- , M R Weir
- & D L Keefe
-
Original Article |
Achieving blood pressure goal: initial therapy with valsartan/hydrochlorothiazide combination compared with monotherapy
- M H Weinberger
- , R D Glazer
- & Y T Chiang
-
Original Article
| Open AccessPreferential benefits of nifedipine GITS in systolic hypertension and in combination with RAS blockade: further analysis of the ‘ACTION’ database in patients with angina
- H L Elliott
- & P A Meredith
-
Original Article
| Open AccessEfficacy and tolerability of amlodipine plus olmesartan medoxomil in patients with difficult-to-treat hypertension
- S G Chrysant
- , J Lee
- & R Heyrman
-
Original Article |
A 52-week prospective, cohort study of the effects of losartan with or without hydrochlorothiazide (HCTZ) in hypertensive patients with metabolic syndrome
- N Racine
- , P Hamet
- & N Bastien
Browse broader subjects
Browse narrower subjects
- Biocatalysis
- Biophysical chemistry
- Biosynthesis
- Carbohydrates
- Chemical ecology
- Chemical genetics
- Chemical libraries
- Chemical modification
- Chemical tools
- Cheminformatics
- Combinatorial libraries
- Computational chemistry
- DNA
- Drug delivery
- Enzyme mechanisms
- Enzymes
- Glycobiology
- Glycomics
- Ion channels
- Kinases
- Lipidomics
- Lipids
- Mechanism of action
- Membranes
- Metabolic pathways
- Metabolomics
- Metals
- Natural products
- Networks and systems biology
- Nucleic acids
- Peptides
- Pharmacology
- Post-translational modifications
- Proteases
- Protein design
- Protein folding
- Proteins
- Proteomics
- RNA
- Screening
- Small molecules
- Synthetic biology
- Target identification
- Target validation
- Transporters